Total Assets: The sum of all assets on a company's balance sheet.
Entero Therapeutics, Inc. (ENTO) had Total Assets of $85.06M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-1.08M |
|
-- |
|
-- |
|
$0.64M |
|
$-0.64M |
|
$-0.04M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-1.00M |
|
$-0.67M |
|
$-0.64M |
|
$-0.64M |
|
4.76M |
|
4.76M |
|
$-0.23 |
|
$-0.23 |
|
Balance Sheet Financials | |
$83.32M |
|
-- |
|
$1.74M |
|
Total Assets |
$85.06M |
$29.68M |
|
-- |
|
-- |
|
$29.68M |
|
$-6.30M |
|
$53.70M |
|
$55.38M |
|
4.77M |
|
Cash Flow Statement Financials | |
$-0.87M |
|
-- |
|
$0.70M |
|
$0.18M |
|
$0.01M |
|
$-0.17M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.81 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.72% |
|
-1.26% |
|
-0.79% |
|
-1.22% |
|
$11.62 |
|
$-0.18 |
|
$-0.18 |